Paul V.

About

Paul joined Agomab Therapeutics in 2021 as Chief Business Officer. Prior to Agomab, he worked at Galapagos (AEX & NASDAQ: GLPG) where he led the corporate development department. In this role he was responsible for all major transactions, licensing, M&A and investments. Before that, he worked at boutique investment bank Kempen & Co in Amsterdam, broking European pharmaceutical & biotech stocks to institutional investors in Europe and the US. Paul is currently a non-executive board member at Molecure in Warsaw, Poland and has a PhD in gynecological oncology from the Erasmus University Medical Center in Rotterdam, The Netherlands. Further interests: Angel investments, research/innovation funding, corporate development & funding advisory Personal interests: Reading, skiing & petrolhead

Experience

• Agomab (Antwerp, Flemish Region, Belgium)
  • Chief Business Officer
    May 2021 - Present · 5 yrs 2 mos

  • Interim Chief Financial Officer
    May 2024 - Nov 2024 · 7 mos

• Chairman of the Board of Directors at Molecure
  Jan 2022 - Present · 4 yrs 6 mos

• Non Executive Director at Immunetune
  Apr 2021 - Jan 2023 · 1 yr 10 mos

• Non Executive Director at Fibrocor Therapeutics
  Jan 2020 - Apr 2021 · 1 yr 4 mos

• Galapagos (Leiden, The Netherlands)
  • Head of Corporate Development
    Apr 2019 - Apr 2021 · 2 yrs 1 mo

  • (Senior) Director - Business Development
    Mar 2016 - Mar 2019 · 3 yrs 1 mo

  • Investor Relations Officer Europe
    Mar 2016 - Sep 2018 · 2 yrs 7 mos